Takeda Pharmaceutical Company Limited Retained Earnings
Takeda Pharmaceutical Company Limited (TAK) had Retained Earnings of JPY 1.19 trillion as of 2025-03-31, per its 20-F filed 2025-06-25.
Financial Statements › Notes
ifrs-full:RetainedEarnings · last filed 2025-06-25
- 2025-03-31: Retained Earnings 1.19T JPY.
- 2024-03-31: Retained Earnings 1.39T JPY.
- 2023-03-31: Retained Earnings 1.54T JPY.
- 2022-03-31: Retained Earnings 1.48T JPY.
| Period end | Retained Earnings | Retained Earnings as first filed |
|---|---|---|
| 2025-03-31 | 1.19T JPY 20-F · filed 2025-06-25 | |
| 2024-03-31 | 1.39T JPY 20-F · filed 2025-06-25 | |
| 2023-03-31 | 1.54T JPY 20-F · filed 2024-06-26 | |
| 2022-03-31 | 1.48T JPY 20-F · filed 2023-06-28 | |
| 2021-03-31 | 1.51T JPY 20-F · filed 2022-06-29 | |
| 2020-03-31 | 1.37T JPY 20-F · filed 2021-06-29 | |
| 2019-03-31 | 1.60T JPY 20-F · filed 2020-06-24 | 1.57T JPY 20-F · filed 2019-06-27 |
| 2018-03-31 | 1.56T JPY 20-F · filed 2019-06-27 |